Immunohistochemical expression of Glut-1 transport protein in primary ovarian cancer - A characteristic feature of the malignant phenotype;Immunhistochemischer nachweis des glukosetransportproteins Glut-1 in primaren ovarialkarzinomen ein charakteristikum des malignen phanotyps

Geburtshilfe und Frauenheilkunde

Volumn 59, Issue 6, 1999, Pages 258-260

  Rudlowski, C ^b   Baumann, R ^b   Rath, W ^b   Schröder, Willibald ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUCOSE TRANSPORTER; MEMBRANE PROTEIN; PEROXIDASE; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; OVARY CANCER; PROTEIN EXPRESSION;

EID: 0033043531     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-14200     Document Type: Article

References (13)

1. Brown, R., J. Leung, S. Fisher, K. Frey, S. Ethier, R. Wahl: Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J. Nucl. Med. 37 (1996) 1042-1047.
2. Brown, R. S., R. L. Wahl: Overexpression of Glut-1 Glucose transporter in human breast cancer. Cancer 72 (1993) 2978-2985.
3. Haber, R. S., A. Tathan, K. R. Weiser, A. Pritsker, A. H. Itzkowitz, C. Bodian, G. Slater, A. Weiss, D. E. Burstein: Glut-1 glucose transporter expression in colorectal carcinoma. Cancer 83 (1998) 34-40.
4. Hawkins, R., C. Hoh, M. Dahlbom, et al.: PET cancer evaluations with FDG (Editorial; Comment). J. Nucl. Med. 32 (1991) 1555-1558.
5. Higashi, T., N. Tamaki, T. Honda, T. Torizuka, T. Kimura, T. Inokuma, G. Ohshio, R. Hosotani, M. Imamura, J. Konishi: Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J. Nucl. Med. 38 (1997) 1337-1344.
6. Klip, A., T. Ramlal, D. A. Young, J. O. Holloszy: Translocation of glucose transporters in rat hindlimb muscles. FEBS lett. 224 (1987) 224-230.
7. Nishioka, T., Y. Oda, Y. Seino, T. Yamamoto, N. Inagaki, H. Yano, H. Imura, R. Shigemot, H. Kikuchi, : Distribution of the glucose transporters in human brain tumors. Cancer Res. 52 (1992) 3972-3979.
8. Pessin, J. E., I. B. Graeme: Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu. Rev. Physiol. 54 (1992) 911-930.
9. Remmele, W., H. E. Stegner: Vorschlag zur einheitlichen Definition eines immunreaktiven Score (IRS) für den immunhistochemischen Ostrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe.
10. Reske, S., K. Grillenberger, G. Glatting, M. Port, M. Hildebrand, F. Gansauge, H. G. Beger: Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J. Nucl. Med. 38 (1997) 1344-1348.
11. 18F-FDG-PET) in diagnosis of ovarian cancer. Int. J. Gynecol. Cancer (1999) im Druck.
12. Warburg, O.: On the origin of cancer cells. Science 123 (1956) 309-314.
13. Younes, M., L. V. Lechago, J. R. Somoano, M. Mosharaf, J., Lechago: Wide expression of the human erythrocyte glucose transporter Glut-1 in human cancers. Cancer Res. 56 (1996) 1164-1167.